Roeker, L., Eyre, T., Thompson, M., Lamanna, N., Coltoff, A., Davids, M., Baker, P., Leslie, L., Rogers, K., Allan, J., Cordoba, R., Lopez-Garcia, A., Antic, D., Pagel, J., Martinez-Calle, N., Garcia-Marco, J., Hernández-Rivas, J., Miras, F., Coombs, C., Österborg, A., Seddon, A., López-Jiménez, J., Wilson, M., El-Sharkawi, D., Wojenski, D., Ma, S., Munir, T., Valenciano, S., Seymour, E., Barr, P., Pu, J., Patten, P., Perini, G., Huntington, S., Parry, H., Sundaram, S., Skarbnik, A., Kamdar, M., Jacobs, R., Walter, H., Walewska, R., Broom, A., Lebowitz, S., Isaac, K., Portell, C., Ahn, I., Ujjani, C., Shadman, M., Skånland, S., Chong, E. & Mato, A. 2021, 'COVID-19 in patients with CLL: improved survival outcomes and update on management strategies', Blood. https://doi.org/10.1182/blood.2021011841